Skip to main content

Johnson & Johnson reports $100 million in quarterly sales from Covid vaccine

J&J's financial results come as the company's Covid-19 vaccine has been put on pause in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.